Relapsed Refractory Diffuse Large B Cell Lymphoma Rr Dlbcl clinical trials

Explore recruiting relapsed refractory diffuse large b cell lymphoma rr dlbcl clinical trials.

Recruiting relapsed refractory diffuse large b cell lymphoma rr dlbcl studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Relapsed Refractory Diffuse Large B Cell Lymphoma Rr Dlbcl trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 2/3, Multicenter Randomized Study of Rituximab-Gemcitabine- Dexamethasone-Platinum (R-GDP) With or Without Selinexor in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (RR DLBCL).

Poland, Spain, Italy

Phase II and Phase III (Integrated) EU CTIS Study details

Relapsed Refractory Diffuse Large B Cell Lymphoma Rr Dlbcl trials by city

Relapsed Refractory Diffuse Large B Cell Lymphoma Rr Dlbcl in Toronto Relapsed Refractory Diffuse Large B Cell Lymphoma Rr Dlbcl in Vancouver Relapsed Refractory Diffuse Large B Cell Lymphoma Rr Dlbcl in Montreal Relapsed Refractory Diffuse Large B Cell Lymphoma Rr Dlbcl in Calgary Relapsed Refractory Diffuse Large B Cell Lymphoma Rr Dlbcl in Edmonton Relapsed Refractory Diffuse Large B Cell Lymphoma Rr Dlbcl in Ottawa Relapsed Refractory Diffuse Large B Cell Lymphoma Rr Dlbcl in Winnipeg Relapsed Refractory Diffuse Large B Cell Lymphoma Rr Dlbcl in Quebec City Relapsed Refractory Diffuse Large B Cell Lymphoma Rr Dlbcl in Hamilton Relapsed Refractory Diffuse Large B Cell Lymphoma Rr Dlbcl in Kitchener Relapsed Refractory Diffuse Large B Cell Lymphoma Rr Dlbcl in London Relapsed Refractory Diffuse Large B Cell Lymphoma Rr Dlbcl in Halifax Relapsed Refractory Diffuse Large B Cell Lymphoma Rr Dlbcl in New York Relapsed Refractory Diffuse Large B Cell Lymphoma Rr Dlbcl in Los Angeles Relapsed Refractory Diffuse Large B Cell Lymphoma Rr Dlbcl in Chicago Relapsed Refractory Diffuse Large B Cell Lymphoma Rr Dlbcl in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease